Obtaining a pancreatic cancer cell line stably expressing doxycycline-dependent endonuclease Cas9
Pancreatic cancer is one of the most painful and aggressive types of cancer with high lethality rate. Early diagnosis of the disease is limited and antitumor therapy has low efficacy, because pancreatic cancer shows multiple drug resistance. It is still unclear how pancreatic tumor cells become resi...
Main Authors: | A.K. Nurgalieva, V.S. Skripova, L.F. Minigulova, R.G. Kiyamova |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazan Federal University
2018-09-01
|
Series: | Učënye Zapiski Kazanskogo Universiteta. Seriâ Estestvennye Nauki |
Subjects: | |
Online Access: | https://kpfu.ru/obtaining-a-pancreatic-cancer-cell-line-stably_382366.html |
Similar Items
-
sgRNA design and in vitro nucleolytic analysis of the Cas9‐RNP complex for transgene‐free genome editing of the eIF4E1 gene from Capsicum an‐ nuum L.
by: Josefanny Tham, et al.
Published: (2023-12-01) -
Novel genome-editing tools to model and correct primary immunodeficiencies
by: Lisa M Ott De Bruin, et al.
Published: (2015-05-01) -
Creation of targeted inversion mutations in plants using an RNA-guided endonuclease
by: Congsheng Zhang, et al.
Published: (2017-02-01) -
In Vivo Structure-Function Analysis and Redox Interactomes of Leishmania tarentolae Erv
by: Gino L. Turra, et al.
Published: (2021-10-01) -
Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology
by: Andrew C. Brane, et al.
Published: (2019-02-01)